EIR Neopharm Labs Sep 2004

Susan Laska FDA$595.00 - Available Now

FDA investigators audited the Neopharm Labs - Blainville, Canada facility and issued inspectional observation (via FDA 483) on 30 Sep 2004.

Product details

  • Category:
  • Inspection end: 30 Sep 2004
  • Location: Blainville, Canada
  • FEI: 3002807703
Add To Cart